Companies

SABIC provides raw material to support domestic production of 50,000 Covid-19 test kits every day in India

Twesh Mishra New Delhi | Updated on May 21, 2020 Published on May 21, 2020

Facing supply chain issues amidst Covid-19 lockdowns

SABIC, a subsidiary of Saudi Aramco operating as a chemical manufacturing company, is providing raw material to enable the domestic production Covid-19 test kits in India. In India, we have been enabling production of around 50,000 Covid-19 test kits a day by supplying healthcare grade material for making test kits cartridges,” said Janardhanan Ramanujalu, Vice-President & Regional Head, SABIC South Asia, Australia & New Zealand

SABIC’s LEXAN PC engineering thermoplastic resin was sent for necessary trials and was approved by the relevant authorities, he said, adding, “Since then, we have been collaborating with our customers and providing the necessary material needed to meet the rising test kit requirements in India.”

“SABIC is also collaborating with customers across India to produce around 80,000 face shields and goggles per day. LEXAN sheets and film, provide high impact strength, optical quality, scratch and chemical resistance and high flexibility for cold curve,” he told BusinessLine.

SABIC is also providing increased volumes to pharmaceutical industry with approved grade of methanol to manufacture Hydroxychloroquine, and other pharma products.

Covid challenges

Commenting on the challenges being faced amidst the Covid-19 lockdowns, Ramanujalu said, “The challenges SABIC faced were similar in nature to rest of the industry, for instance, shortage of delivery drivers and trucks, and lack of manpower to operate the warehouse to supply critical material required by our customers to produce medical equipment for combating the virus in the initial phase of lockdown.”

In response to a query on the companies that are buying from SABIC, he said, “While in general, we serve customers across packaging, healthcare, consumer electronics, automotive, building and construction and agriculture industry in India – specific to Covid-19, we have been leveraging our technological and research capabilities to help our customers across healthcare and pharma sectors.”

He also said SABIC has been supporting requirements across India by means of material import and domestic production through their manufacturing plant in Gujarat.

Published on May 21, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.